Studies and Information
A Study of 532 Patients Indicating The Clinical Success of The ReBuilder for Neuropathy.
"91% of respondents reported an improvement in their quality of life"
"The ReBuilder is an effective, drug free, side effect free, primary treatment for neuropathy"
Cancer Treatment Centers of American letter about the ReBuilder Treatment System.
"I want to personally thank you for inventing and developing the ReBuilder System…"
"With these remarkable results (96% success rate) the ReBuilder System is now being used across all four CTCA sites…"
"We believe in your product's ability to alleviate CIPN symptoms for cancer patients receiving chemotherapy. Patients have reduced or stopped taking pain medicine such as Gabapentin and Lyrica for CIPN."
Safety and Efficacy of the ReBuilder in Treating Peripheral Neuropathy
A slideshow highlighting the protocol and results using the ReBuilder. Read more.
New Treatment of Painful Diabetic Neuropathy with Electronic Neuromuscular Stimulator
"Pain levels were reduced in all 6 patients. Original pain levels ranged form 5 to 10. The average reduction on the pain scale was three levels after a two-weeks and five levels by the end of the study. Four of the patients had trouble falling to sleep before the study and all noted improvement within two days of starting the neuromuscular stimulator."
"No adverse reactions or allergies were reported."
ReBuilder Effectiveness with 134 patients
"The ReBuilder TENS unit provides acceptable pain and neuropathy symptom relief for patients with VD, DM, Alcoholism and Chemotherapy agents and is very easy for patients to self-administer."
Return to previous page